APOL1 research is driving precision nephrology, but prediction gaps and equity challenges still limit clinical impact.
Kirk Campbell, MD
Advertisement
Professor of Medicine and Renal Division Chief at the University of Pennsylvania Perelman School of Medicine
Articles by Kirk Campbell, MD
Campbell answers questions about the current research and clinical landscape of APOL1-mediated kidney disease.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Diabetes Increases Mortality Risk Across All Major Organ Transplants
2
What Are Some Clinical Pearls in Pediatric Dermatology? With Lisa Swanson, MD
3
How to Counsel Patients About Skincare Safety, Sunscreen Safety, and Product Ingredients
4
Plasma EV Analysis Identifies Proteins Associated With T1D Risk, With Ernesto Nakayasu, PhD
5